You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Rheumatoid Arthritis: Front Row Seat at the Fall Rheumatology Conference

  • Authors: Kenneth Kalunian, MD; Iain McInnes, MD, PhD; and Yusuf Yazici, MD
  • CME / ABIM MOC Released: 12/13/2019
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 12/13/2020, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for rheumatologists, primary care physicians, and orthopaedists & orthopaedic surgeons.

The goal of this activity is to increase clinicians’ knowledge regarding the latest data in the treatment of rheumatoid arthritis.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding
    • Data on emerging therapies in RA
    • Data on JAK inhibitors for RA


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Kenneth Kalunian, MD

    Professor of Medicine
    Division of Rheumatology, Allergy, and Immunology
    University of California, San Diego School of Medicine
    La Jolla, California, United States

    Disclosures

    Disclosure: Kenneth Kalunian, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Amgen Inc.; AstraZeneca Pharmaceuticals LP; Biogen; Bristol-Myers Squibb Company; Celgene Corporation; Equillium; Genentech, Inc.; GlaxoSmithKline; Janssen Pharmaceuticals; Kyowa Kirin Pharmaceutical Development, Inc.; Nektar; Pfizer Inc.; Roche; Takeda Pharmaceuticals North America, Inc.; Viela Bio
    Received grants for clinical research from: Corbus; Irdosia; Resolve Therapeutics

Panelist

  • Iain B. McInnes, MD, PhD

    Muirhead Professor of Medicine
    ARUK Professor of Rheumatology
    Director
    Institute of Infection, Immunity, and Inflammation
    College of Medical, Veterinary, and Life Sciences
    Glasgow Biomedical Research Centre
    University of Glasgow
    Scotland, United Kingdom

    Disclosures

    Disclosure: Iain B. McInnes, MD, PhD has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Janssen Pharmaceuticals; Lilly; Novartis Pharmaceuticals Corporation; UCB Pharma, Inc.
    Received grants for clinical research from: Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; UCB Pharma, Inc.

  • Yusuf Yazici, MD

    Clinical Associate Professor of Medicine
    New York University School of Medicine
    Director
    Seligman Center for Advanced Therapeutics
    Behcet’s Syndrome Evaluation, Treatment and Research Center
    NYU Hospital for Joint Diseases
    New York, New York, United States

    Disclosures

    Disclosure: Yusuf Yazici, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Bristol-Myers Squibb Company; Celgene Corporation; Sanofi
    Received grants for clinical research from: Bristol-Myers Squibb Company; Celgene Corporation

Editors

  • Karen Badal, MD, MPH

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Karen Badal, MD, MPH, has disclosed the following relevant financial relationships:
    Owns stocks, stock options or bonds from: Kallyope, Inc.

  • Heather Lewin, MAT

    Senior Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Heather Lewin, MAT, has disclosed no relevant financial relationships.

CME Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

Medscape, LLC staff have disclosed that they have no relevant financial relationships.


Accreditation Statements

Medscape

 
Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Rheumatoid Arthritis: Front Row Seat at the Fall Rheumatology Conference

Authors: Kenneth Kalunian, MD; Iain McInnes, MD, PhD; and Yusuf Yazici, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC Released: 12/13/2019

Valid for credit through: 12/13/2020, 11:59 PM EST

processing....

Educational Impact Challenge

The goal of this activity is to increase clinicians’ knowledge regarding the latest data in the treatment of rheumatoid arthritis.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print